Patents by Inventor Martha J. Morrell
Martha J. Morrell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230172529Abstract: A method of assessing electrical activity of a brain includes, for each of a plurality of electrical-activity records of the brain, applying a machine-learned ESC model to the record to classify the record as one of a seizure record or a non-seizure record, wherein each of record is sensed by a corresponding one of a plurality of sensing channels of an implanted medical device; for each seizure record in a set of seizure records, applying the machine-learned ESC model to the seizure record to classify the seizure record as one of a local-seizure record or a spread-seizure record, wherein the seizure record comprises a first seizure record captured by a first sensing channel and a second seizure record captured by a second sensing channel; and for each spread-seizure record in a set of spread-seizure records, applying a machine-learned SSC model to the spread-seizure record to classify the spread-seizure record as a type of seizure spread pattern.Type: ApplicationFiled: November 29, 2022Publication date: June 8, 2023Inventors: Sharanya Arcot Desai, Thomas K. Tcheng, Cairn G. Seale, Martha J. Morrell, David A. Greene
-
Publication number: 20220323019Abstract: A clinical response estimate (CRE) biomarker of a patient having an implanted neurostimulation system is monitored. To this end, an input dataset is derived from a subject-patient dataset that includes various different data types and different features of the patient. The data types are based on electrical activity the patient's brain sensed and stored by the implanted neurostimulation system. The input dataset is a subset of the larger subject-patient dataset, and the specific data types and patient features included in that subset are derived based on a plurality of key inputs of the subject-patient dataset. Once the input dataset is derived, it is processed by a clinical response estimator having machine-learned models. First and second machine-learned models of the clinical response estimator are applied to the input dataset to provide model inputs to an ensemble machine-learned model to determine the CRE biomarker.Type: ApplicationFiled: March 30, 2022Publication date: October 13, 2022Inventors: Sharanya Arcot Desai, Tara L. Crowder, Thomas K. Tcheng, Martha J. Morrell, Lise Johnson Dyhr
-
Publication number: 20220313159Abstract: An input dataset is processed to obtain a pre-event window of model inputs and a post-event window of model inputs. The input dataset is a subset of a larger subject-patient dataset that includes different data types and features of the patient. The data types are based on electrical activity of the patient's brain that is sensed and stored by an implanted neurostimulation system. A clinical response estimator (CRE) model is applied to the pre-event window of model inputs to derive pre-event CRE biomarkers. The CRE model is also applied to the post-event window of model inputs to derive post-event CRE biomarkers. The pre-event CRE biomarkers and post-event CRE biomarkers are displayed as a function of time together with the occurrence of the event of interest.Type: ApplicationFiled: March 30, 2022Publication date: October 6, 2022Inventors: Sharanya Arcot Desai, Tara L. Crowder, Thomas K. Tcheng, Martha J. Morrell, Lise Johnson Dyhr
-
Publication number: 20210298654Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.Type: ApplicationFiled: June 14, 2021Publication date: September 30, 2021Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
-
Patent number: 11064926Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.Type: GrantFiled: November 17, 2017Date of Patent: July 20, 2021Assignee: NeuroPace, Inc.Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
-
Publication number: 20180085015Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.Type: ApplicationFiled: November 17, 2017Publication date: March 29, 2018Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
-
Patent number: 9265946Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: GrantFiled: September 4, 2015Date of Patent: February 23, 2016Assignee: NeuroPace, Inc.Inventor: Martha J. Morrell
-
Patent number: 9265931Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: GrantFiled: September 3, 2015Date of Patent: February 23, 2016Assignee: NeuroPace, Inc.Inventor: Martha J. Morrell
-
Publication number: 20150374993Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: ApplicationFiled: September 4, 2015Publication date: December 31, 2015Inventor: Martha J. MORRELL
-
Publication number: 20150374973Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: ApplicationFiled: September 3, 2015Publication date: December 31, 2015Inventor: Martha J. MORRELL
-
Patent number: 9162052Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: GrantFiled: September 7, 2009Date of Patent: October 20, 2015Assignee: NeuroPace, Inc.Inventor: Martha J. Morrell
-
Patent number: 9162051Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: GrantFiled: September 21, 2006Date of Patent: October 20, 2015Assignee: NeuroPace, Inc.Inventor: Martha J. Morrell
-
Publication number: 20130172774Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.Type: ApplicationFiled: June 30, 2012Publication date: July 4, 2013Applicant: NEUROPACE, INC.Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
-
Patent number: 8423156Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Methods described herein may comprise contacting the substrate of a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: GrantFiled: February 9, 2012Date of Patent: April 16, 2013Assignee: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20120232628Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Methods described herein may comprise contacting the substrate of a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: ApplicationFiled: February 9, 2012Publication date: September 13, 2012Applicant: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20110004282Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Examples of bioactive agents that may be used in the lead system include bioactive agents that promote neural adhesion and living cells that have been biologically manipulated, engineered cells, and cells of a particular phenotype and/or adapted to induce a desired neural or glial response.Type: ApplicationFiled: August 30, 2010Publication date: January 6, 2011Applicant: NEUROPACE, INC.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20100331762Abstract: Medical electrical lead systems and related methods are described. The medical electrical lead systems may be configured to be at least partially implanted in a body of a subject. Some variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and a lumen extending at least partially therebetween, at least one electrode in the proximity of the distal end of the lead body, and a reservoir in fluid communication with the lumen, where the reservoir is located at a position removed from the distal end of the lead body. Certain variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and first and second lumens extending at least partially therebetween, and at least one electrode in the proximity of the distal end of the lead body.Type: ApplicationFiled: September 13, 2010Publication date: December 30, 2010Applicant: NeuroPace, Inc.Inventors: Brett M. Wingeier, Martha J. Morrell, C. Lance Boling
-
Patent number: 7844345Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Examples of bioactive agents that may be used in the lead system include antiproliferative agents, bactericidal agents, bacteriostatic agents, antiepileptic agents, and/or antifungal agents. Methods described herein may comprise coating a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: GrantFiled: February 8, 2007Date of Patent: November 30, 2010Assignee: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Patent number: 7813811Abstract: Medical electrical lead systems and related methods are described. The medical electrical lead systems may be configured to be at least partially implanted in a body of a subject. Some variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and a lumen extending at least partially therebetween, at least one electrode in the proximity of the distal end of the lead body, and a reservoir in fluid communication with the lumen, where the reservoir is located at a position removed from the distal end of the lead body. Certain variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and first and second lumens extending at least partially therebetween, and at least one electrode in the proximity of the distal end of the lead body.Type: GrantFiled: February 8, 2007Date of Patent: October 12, 2010Assignee: NeuroPace, Inc.Inventors: Brett M. Wingeier, Martha J. Morrell, C. Lance Boling
-
Publication number: 20090326605Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.Type: ApplicationFiled: September 7, 2009Publication date: December 31, 2009Inventor: Martha J. Morrell